Page last updated: 2024-09-04

delta9-tetrahydrocannabinol hemisuccinate and piperidines

delta9-tetrahydrocannabinol hemisuccinate has been researched along with piperidines in 1 studies

Compound Research Comparison

Studies
(delta9-tetrahydrocannabinol hemisuccinate)
Trials
(delta9-tetrahydrocannabinol hemisuccinate)
Recent Studies (post-2010)
(delta9-tetrahydrocannabinol hemisuccinate)
Studies
(piperidines)
Trials
(piperidines)
Recent Studies (post-2010) (piperidines)
141440,2355,22114,545

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambrosio, E; Arévalo, C; Cascio, MG; Di Marzo, V; Fernández-Ruiz, J; González, S; Hernández, M; Nicanor, C; Ramos, JA1

Other Studies

1 other study(ies) available for delta9-tetrahydrocannabinol hemisuccinate and piperidines

ArticleYear
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    Drug and alcohol dependence, 2004, May-10, Volume: 74, Issue:2

    Topics: Animals; Arachidonic Acids; Behavior, Animal; Brain; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Corticosterone; Dronabinol; Drug Administration Schedule; Drug Tolerance; Endocannabinoids; Glycerides; Male; Paraventricular Hypothalamic Nucleus; Piperidines; Polyunsaturated Alkamides; Prolactin; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Corticotropin-Releasing Hormone; Rimonabant; RNA, Messenger; Substance Withdrawal Syndrome

2004